Skip to main content

Site notifications

Tell us about your search experience on the TGA website - complete our short survey

Sub menu

News and Community
About us

Search

Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

You are here

Home
Guidance and resources
Sponsors

GlaxoSmithKline Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- Twitter
- Facebook
- Email

Loading...

Type

Laboratory test report (507)
Cancellation by sponsor (158)
ARTG (137)
Australian Public Assessment Report (AusPAR) (38)
Prescription medicine registration (16)
Designation or determination (3)
Prescription medicine decision summary (2)
Face mask cancellation (1)
Prescription medicine evaluation (1)

Date

2023 (14)
2022 (169)
2021 (139)
2020 (66)
2019 (35)
2018 (27)
2017 (27)
2016 (12)
2015 (52)
2014 (25)
2013 (10)
2012 (7)
2011 (5)
2010 (7)
2009 (4)
2008 (7)
2007 (9)
2006 (3)
2005 (4)
2004 (2)
2003 (3)
2002 (3)
2001 (4)
2000 (3)
1999 (4)
1998 (5)
1997 (5)
1995 (1)
1992 (2)
1991 (8)

Search

Sponsor content

863 result(s) found, displaying 1 to 10

31 July 2023

Laboratory test report

RABIPUR rabies virus vaccine (Inactivated) 2.5 IU powder for injection vial with diluent pre-filled syringe (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
31 July 2023

Laboratory test report

RABIPUR rabies virus vaccine (Inactivated) 2.5 IU powder for injection vial with diluent pre-filled syringe (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
31 July 2023

Laboratory test report

RABIPUR rabies virus vaccine (Inactivated) 2.5 IU powder for injection vial with diluent pre-filled syringe (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
31 July 2023

Laboratory test report

RABIPUR rabies virus vaccine (Inactivated) 2.5 IU powder for injection vial with diluent pre-filled syringe (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
30 April 2023

Laboratory test report

ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
30 April 2023

Laboratory test report

ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
30 April 2023

Laboratory test report

ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
30 April 2023

Laboratory test report

ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
28 February 2023

Laboratory test report

RABIPUR rabies virus vaccine (Inactivated) 2.5 IU powder for injection vial with diluent pre-filled syringe (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS
28 February 2023

Laboratory test report

RABIPUR rabies virus vaccine (Inactivated) 2.5 IU powder for injection vial with diluent pre-filled syringe (GlaxoSmithKline Australia Pty Ltd)

Batch Release - PASS

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
Twitter
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia